BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33571476)

  • 1. Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision.
    Niederer RL; Meyer JJ; Liu K; Danesh-Meyer HV
    Am J Ophthalmol; 2021 Jun; 226():83-89. PubMed ID: 33571476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus.
    Szeto SK; Chan TC; Wong RL; Ng AL; Li EY; Jhanji V
    Cornea; 2017 Mar; 36(3):338-342. PubMed ID: 27741018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients.
    Nithyanandam S; Joseph M; Stephen J
    Int J STD AIDS; 2013 Feb; 24(2):106-9. PubMed ID: 23512510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting visual outcome in herpes zoster ophthalmicus: a prospective study.
    Nithyanandam S; Stephen J; Joseph M; Dabir S
    Clin Exp Ophthalmol; 2010 Dec; 38(9):845-50. PubMed ID: 20572824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveitis in Herpes zoster ophthalmicus.
    Thean JH; Hall AJ; Stawell RJ
    Clin Exp Ophthalmol; 2001 Dec; 29(6):406-10. PubMed ID: 11778812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years.
    Ghaznawi N; Virdi A; Dayan A; Hammersmith KM; Rapuano CJ; Laibson PR; Cohen EJ
    Ophthalmology; 2011 Nov; 118(11):2242-50. PubMed ID: 21788078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.
    Borkar DS; Tham VM; Esterberg E; Ray KJ; Vinoya AC; Parker JV; Uchida A; Acharya NR
    Ophthalmology; 2013 Mar; 120(3):451-456. PubMed ID: 23207173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic Keratopathy After Herpes Zoster Ophthalmicus.
    Meyer JJ; Liu K; McGhee CNJ; Danesh-Meyer HV; Niederer RL
    Cornea; 2022 Nov; 41(11):1433-1436. PubMed ID: 35120347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations in herpes zoster ophthalmicus.
    Puri LR; Shrestha GB; Shah DN; Chaudhary M; Thakur A
    Nepal J Ophthalmol; 2011; 3(2):165-71. PubMed ID: 21876592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States.
    Edell AR; Cohen EJ
    Eye Contact Lens; 2013 Jul; 39(4):311-4. PubMed ID: 23771014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Profile of Herpes Zoster Ophthalmicus in a South Indian Patient Population.
    Babu K; Mahendradas P; Sudheer B; Kawali A; Parameswarappa DC; Pal V; Philips M
    Ocul Immunol Inflamm; 2018; 26(2):178-183. PubMed ID: 29072860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations.
    Dmitriev AA; Odden J; Mora-Boellstorff D; Kinchington PR; Sheridan K; Viehman JA; Price D; Koscumb S; Marroquin O; Sahel JA; Kowalski RP; Jhanji V; Errera MH
    Can J Ophthalmol; 2024 Jun; 59(3):201-207. PubMed ID: 37192736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.
    Tran KD; Falcone MM; Choi DS; Goldhardt R; Karp CL; Davis JL; Galor A
    Ophthalmology; 2016 Jul; 123(7):1469-75. PubMed ID: 27067924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical presentations of Herpes Zoster Ophthalmicus (diagnosis and therapy)].
    Chernakova GM; Kleshcheva EA; Semenova TB
    Vestn Oftalmol; 2016; 132(5):75-80. PubMed ID: 27911430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of penetrating keratoplasty for corneal complications of herpes zoster ophthalmicus.
    Tanaka TS; Hood CT; Kriegel MF; Niziol L; Soong HK
    Br J Ophthalmol; 2019 Dec; 103(12):1710-1715. PubMed ID: 30733209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethylenediaminetetraacetic Acid Chelation in Herpes Zoster Ophthalmicus Is Associated With a High Rate of Corneal Melt and Perforation.
    Trollip JC; Meyer JJ; McGhee CNJ; Liu K; Danesh-Meyer HV; Niederer RL
    Cornea; 2021 Mar; 40(3):277-281. PubMed ID: 33264147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic and Recurrent Herpes Zoster Ophthalmicus.
    Lee SM; Han J; Yang CM; Choi CY; Khoramnia R; Chung TY; Lim DH
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684035
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes zoster ophthalmicus: acute keratitis.
    Li JY
    Curr Opin Ophthalmol; 2018 Jul; 29(4):328-333. PubMed ID: 29794881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention.
    Litt J; Cunningham AL; Arnalich-Montiel F; Parikh R
    Infect Dis Ther; 2024 Jun; ():. PubMed ID: 38834857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes Zoster Optic Neuropathy.
    Kaufman AR; Myers EM; Moster ML; Stanley J; Kline LB; Golnik KC
    J Neuroophthalmol; 2018 Jun; 38(2):179-189. PubMed ID: 29266031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.